Literature DB >> 1762696

Spectrin breakdown products increase with age in telencephalon of mouse brain.

B A Bahr1, P W Vanderklish, L T Ha, M T Tin, G Lynch.   

Abstract

Calcium activated proteolysis of brain spectrin produces characteristic breakdown products (BDPs), the concentrations of which increase markedly in many instances of brain pathology. Results reported here indicate that levels of the BDPs rise with age (3-30 months) in the telencephalon but not in the hindbrain of Balb/c mice. These observations suggest that spectrin breakdown is a pathologic biochemical marker which increases with age in some but not all brain regions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1762696     DOI: 10.1016/0304-3940(91)90622-z

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Increased immunoreactivities of cleaved αII-spectrin and cleaved caspase-3 in the aged dog spinal cord.

Authors:  In Koo Hwang; Ji Hyeon Ahn; Dae Young Yoo; Choong Hyun Lee; Ki-Yeon Yoo; Jung Hoon Choi; Seung Myung Moon; Hyung-Cheul Shin; Moo-Ho Won
Journal:  Neurochem Res       Date:  2011-10-30       Impact factor: 3.996

2.  Spectrin Breakdown Products (SBDPs) as Potential Biomarkers for Neurodegenerative Diseases.

Authors:  Xiao-Xin Yan; Andreas Jeromin; A Jeromin
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2012-06

Review 3.  The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states.

Authors:  P W Vanderklish; B A Bahr
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

4.  Age-related intraneuronal elevation of αII-spectrin breakdown product SBDP120 in rodent forebrain accelerates in 3×Tg-AD mice.

Authors:  Yan Cai; Hai-Xia Zhu; Jian-Ming Li; Xue-Gang Luo; Peter R Patrylo; Gregory M Rose; Jackson Streeter; Ron Hayes; Kevin K W Wang; Xiao-Xin Yan; Andreas Jeromin
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

5.  Frataxin-deficient neurons and mice models of Friedreich ataxia are improved by TAT-MTScs-FXN treatment.

Authors:  Elena Britti; Fabien Delaspre; Anat Feldman; Melissa Osborne; Hagar Greif; Jordi Tamarit; Joaquim Ros
Journal:  J Cell Mol Med       Date:  2017-10-05       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.